In this study, we found that high expression of GATA3 is associated with a better prognosis, similar to that observed in luminal breast cancer [38]. Moreover, the expression of GATA3 protein can be assessed in surgical or biopsy specimens, which may offer a basis for early clinical treatment decisions. This evidence concerns the gene GATA3 and breast cancer.